Drug profile · INN
hydroxychloroquine sulfate
HYDROXYCHLOROQUINE SULFATE
hydroxychloroquine sulfate (HYDROXYCHLOROQUINE SULFATE) is a toll-like receptor 9 antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — hydroxychloroquine sulfate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 7
- Data quality
- 0.89
Quick answer
hydroxychloroquine sulfate (HYDROXYCHLOROQUINE SULFATE) is a toll-like receptor 9 antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Toll-like receptor 9 antagonist
Primary target: Ferriprotoporphyrin IX
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is hydroxychloroquine sulfate?
hydroxychloroquine sulfate (HYDROXYCHLOROQUINE SULFATE) is a toll-like receptor 9 antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for hydroxychloroquine sulfate?
HYDROXYCHLOROQUINE SULFATE is a marketed brand name for hydroxychloroquine sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hydroxychloroquine sulfate?
hydroxychloroquine sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.